After subcutaneous inoculation of EoL-1 cells (2 × 107/100 μL) or EoL-1R cells (1 × 107/100 μL), we evaluated the tumor volume and weight and the alteration of PDGFRα activation by immunohistochemistry and Western blotting. The gene discussed is PDGFRA; the disease is neoplasm.